Eton Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	865	457	356	113	71	106
Market Cap Growth	70.55%	28.56%	216.20%	57.37%	-32.32%	-46.55%
Enterprise Value	876.93	462.44	370.75	96.53	61.71	97.93
Last Close Price	31.59	16.91	13.32	4.38	2.82	4.29
Forward PE	35.23	30.56	57.91	79.64	-	9.98
PS Ratio	9.95	5.72	9.12	3.56	3.36	4.84
PB Ratio	28.23	17.49	14.56	7.27	5.47	5.99
P/FCF Ratio	56.08	44.88	377.27	16.51	14.95	-
P/OCF Ratio	54.63	43.46	367.15	16.51	14.83	-
EV/Sales Ratio	10.09	5.78	9.50	3.05	2.90	4.49
EV/EBITDA Ratio	79.11	144.51	-	-	-	-
EV/FCF Ratio	56.83	45.38	393.16	14.16	12.90	-
Debt / Equity Ratio	1.02	1.19	1.22	0.00	0.42	0.30
Debt / EBITDA Ratio	5.03	9.69	-	-	-	-
Debt / FCF Ratio	2.02	3.04	31.73	0.79	1.36	-
Net Debt / Equity Ratio	0.38	0.19	0.61	-1.03	-0.75	-0.44
Net Debt / EBITDA Ratio	1.86	1.59	-10.32	54.94	1.51	7.47
Net Debt / FCF Ratio	0.75	0.50	15.89	-2.35	-2.04	1.63
Asset Turnover	0.92	0.95	0.72	1.11	0.81	0.81
Inventory Turnover	2.63	2.43	1.93	14.42	12.53	3.16
Quick Ratio	0.75	0.98	1.02	1.53	2.81	4.36
Current Ratio	1.21	1.57	2.06	1.65	3.10	5.18
Return on Equity (ROE)	-5.20%	-18.19%	-19.16%	-6.56%	-58.75%	-11.74%
Return on Assets (ROA)	2.13%	-1.01%	-4.83%	-5.70%	-31.47%	-5.56%
Return on Invested Capital (ROIC)	4.19%	-2.09%	-10.12%	-19.82%	-103.39%	-25.30%
Return on Capital Employed (ROCE)	3.81%	-1.54%	-7.25%	-7.00%	-39.83%	-6.58%
FCF Yield	1.78%	2.23%	0.27%	6.06%	6.69%	-
Buyback Yield / Dilution	-3.18%	-3.91%	-0.97%	-1.99%	0.24%	-19.98%
Total Shareholder Return	-3.18%	-3.91%	-0.97%	-1.99%	0.24%	-19.98%

SEC Filings: 10-K · 10-Q